Subtype
Malignant Female Reproductive System Neoplasm
CI-CAN-00003157Explore in graph →
1,462 active trials11 approved drugs128 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003157Explore in graph →
Clinical trials
6,252 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (740)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07092007 | NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT06473766 | Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses(RFDATA) | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 18, 2025 |
| clinicaltrials |
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study(INSPIRE) | unknown | — | 5,350 | Singlera Genomics Inc.INDUSTRY | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06353061 | Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer | unknown | Phase 2 | 51 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06237257 | A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer | unknown | Phase 2 | 56 | Shanghai Shengdi Pharmaceutical Co., LtdINDUSTRY | 1 | Dec 24, 2024 | clinicaltrials |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06741150 | NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06541314 | Fluzoparib Neoadjuvant Therapy for Ovarian Cancer | unknown | Phase 2 | 48 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT06163963 | Sentinel Lymph Node in Early-Stage Endometrium Cancer | unknown | N/A | 100 | Istanbul UniversityOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06339684 | HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis(HPVImmuno) | unknown | — | 120 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | unknown | Phase 1 / Phase 2 | 179 | NGM Biopharmaceuticals, IncINDUSTRY | 3 | Oct 2, 2024 | clinicaltrials |
| NCT05793333 | Predictors of Node Positivity in Endometrial Cancer | unknown | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598085 | Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery | unknown | N/A | 20 | Cornerstone RoboticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05099978 | Asian Multicenter Prospective Study of ctDNA Sequencing(A-TRAIN) | unknown | — | 506 | National Cancer Center, JapanOTHER_GOV | 8 | Sep 4, 2024 | clinicaltrials |
| NCT06574763 | Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer | unknown | Phase 2 | 47 | Sun Yat-sen UniversityOTHER | 0 | Aug 28, 2024 | clinicaltrials |
| NCT05475184 | A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor | unknown | Phase 2 | 58 | Onconic Therapeutics Inc.INDUSTRY | 1 | Aug 27, 2024 | clinicaltrials |
| NCT05684731 | Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer(K19017-004) | unknown | Phase 1 | 30 | Tongji HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550583 | Screening for Early Cervical Cancer Detection | unknown | — | 200 | Assiut UniversityOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT05025878 | 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.(iMETABO) | unknown | — | 10 | British Columbia Cancer AgencyOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT04787289 | A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer | unknown | Phase 2 | 244 | British Columbia Cancer AgencyOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT02991677 | Exercise Effect on Chemotherapy-Induced Neuropathic Pain | unknown | N/A | 60 | Baltimore VA Medical CenterFED | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06536855 | Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda | unknown | Phase 4 | 100,000 | Rwanda Biomedical CentreOTHER | 0 | Aug 5, 2024 | clinicaltrials |
| NCT06533709 | Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data | unknown | — | 146 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT03366051 | Sentinel Node Mapping in High Risk Endometrial Cancer(ALICE) | unknown | N/A | 178 | AC Camargo Cancer CenterOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06515678 | Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension(IATRO) | unknown | — | 9,464 | Groupe Hospitalier Pitie-SalpetriereOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06521684 | Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma | unknown | — | 110 | Peking Union Medical College HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT05554276 | Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer(PD-1) | unknown | Phase 2 | 36 | Shanghai Jiao Tong University Affiliated Sixth People's HospitalOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT05776693 | Relationships Among Physical and Psychological Status, Social Support, Resource Utilization, Supportive Care Needs in Patients With Gynecological Cancer | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06509529 | The Effect of Motivational Interviewing Based on the COM-B Model | unknown | N/A | 68 | Ordu UniversityOTHER | 0 | Jul 19, 2024 | clinicaltrials |
| NCT03614689 | Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire | unknown | — | 104 | Geneplus-Beijing Co. Ltd.INDUSTRY | 1 | Jul 18, 2024 | clinicaltrials |
| NCT05675787 | Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia | unknown | Phase 2 | 82 | Peking University People's HospitalOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT03340376 | Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer | unknown | Phase 2 | 48 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05610501 | Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 4 | Jul 3, 2024 | clinicaltrials |
| NCT06456112 | Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV | unknown | — | 83 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 1, 2024 | clinicaltrials |
| NCT04432857 | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors | unknown | Phase 1 | 63 | Adlai Nortye Biopharma Co., Ltd.INDUSTRY | 2 | Jun 27, 2024 | clinicaltrials |
| NCT06468254 | An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer | unknown | Phase 2 | 500 | Anhui Provincial Cancer HospitalOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06018935 | A Cohort Establishment Study of Total Management of Ovarian Cancer | unknown | — | 500 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06455072 | Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer | unknown | Phase 2 | 37 | Fujian Cancer HospitalOTHER_GOV | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05607602 | Are Uterine Fibroids Pro-thrombotic? | unknown | — | 105 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06293066 | Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study. | unknown | — | 330 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06448897 | Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques. | unknown | — | 4,000 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT06445621 | Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test(FOLL-OV) | unknown | — | 125 | Uppsala University HospitalOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT06250010 | Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence | unknown | — | 30 | Regina Elena Cancer InstituteOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06431724 | A Review of Cervical Cancer Screening Practices in Women Age >65 | unknown | — | 300 | Sarasota Memorial Health Care SystemOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05955105 | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 200 | Innolake BiopharmINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT06278610 | Pelvic Exenteration and Laterally Extended Pelvic Resection(Pre-PEX) | unknown | — | 85 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT05385406 | HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid | unknown | N/A | 5,500 | Prof. Patrick PetignatOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06377267 | Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)(STROBE) | unknown | Phase 2 | 100 | Vall d'Hebron Institute of OncologyOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406322 | Pelvic Floor Dysfunction and Aerobic Training in Gynecological Cancer | unknown | N/A | 40 | Atılım UniversityOTHER | 0 | May 9, 2024 | clinicaltrials |
| NCT00892866 | CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | unknown | N/A | 877 | GOG FoundationNETWORK | 3 | May 3, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jul 29, 2025source: clinicaltrials